HealthEquity (NASDAQ:HQY) PT Raised to $108.00 at JPMorgan Chase & Co.

HealthEquity (NASDAQ:HQY - Free Report) had its price target boosted by JPMorgan Chase & Co. from $86.00 to $108.00 in a report issued on Tuesday morning, Marketbeat.com reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

A number of other equities research analysts also recently weighed in on the stock. Barrington Research reiterated an outperform rating and set a $100.00 price target on shares of HealthEquity in a research note on Friday, March 22nd. Wells Fargo & Company lifted their price target on shares of HealthEquity from $89.00 to $93.00 and gave the stock an overweight rating in a research note on Wednesday, December 6th. Bank of America lifted their price target on shares of HealthEquity from $93.00 to $97.00 and gave the stock a buy rating in a research note on Wednesday, March 20th. KeyCorp boosted their target price on shares of HealthEquity from $85.00 to $95.00 and gave the company an overweight rating in a research note on Friday, March 22nd. Finally, Raymond James boosted their target price on shares of HealthEquity from $90.00 to $95.00 and gave the company an outperform rating in a research note on Wednesday, December 13th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus target price of $95.73.

HealthEquity Stock Performance

HQY stock traded up $1.16 on Tuesday, reaching $82.79. 844,583 shares of the company were exchanged, compared to its average volume of 610,949. HealthEquity has a 12 month low of $48.86 and a 12 month high of $84.49. The stock's fifty day moving average price is $80.37 and its 200 day moving average price is $73.62. The firm has a market capitalization of $7.10 billion, a PE ratio of 129.35, a PEG ratio of 1.38 and a beta of 0.53. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 2,499 shares of the company's stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares of the company's stock, valued at approximately $3,999,680. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CEO Jon Kessler sold 33,765 shares of the company's stock in a transaction dated Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company's stock, valued at approximately $10,106,739.35. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 2,499 shares of the business's stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the transaction, the executive vice president now owns 49,996 shares of the company's stock, valued at $3,999,680. The disclosure for this sale can be found here. In the last three months, insiders sold 73,908 shares of company stock valued at $5,863,915. 2.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On HealthEquity

Large investors have recently made changes to their positions in the stock. Comerica Bank boosted its holdings in shares of HealthEquity by 82,280.3% in the 3rd quarter. Comerica Bank now owns 58,490 shares of the company's stock valued at $4,273,000 after buying an additional 58,419 shares during the last quarter. Natixis Advisors L.P. raised its stake in HealthEquity by 7.2% in the 3rd quarter. Natixis Advisors L.P. now owns 17,664 shares of the company's stock valued at $1,290,000 after acquiring an additional 1,180 shares during the period. Portside Wealth Group LLC bought a new stake in HealthEquity in the 2nd quarter valued at $5,162,000. Gotham Asset Management LLC bought a new stake in HealthEquity in the 3rd quarter valued at $1,103,000. Finally, Loomis Sayles & Co. L P raised its stake in HealthEquity by 57.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 399,683 shares of the company's stock valued at $29,197,000 after acquiring an additional 146,372 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.